Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-12-039895
Filing Date
2012-05-24
Accepted
2012-05-24 21:31:15
Documents
1
Period of Report
2012-05-23

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4028
  Complete submission text file 0001104659-12-039895.txt   5476
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3172 PORTER DRIVE PALO ALTO CA 94034
Business Address
SPIEGELMAN DANIEL K (Reporting) CIK: 0001238403 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 12869140